#NatCancer
LightNews LightNews
natcancer.nature.com
🎂Our 5-YEAR ANNIVERSARY Issue is now ONLINE!
@NatureCancer

Find it here:
www.nature.com/natcancer/vo...

Features:
⭐️Reviews and opinion pieces
⭐️Research articles
on key developments in #cancerresearch and #oncology
January 30, 2025 at 4:31 PM
meravcohenlab.bsky.social
Thank you @naturecancer.bsky.social for selecting our study to be featured on the cover of the monthly issue!
www.nature.com/natcancer/vo...

@sandracamargog.bsky.social @orimoskowitz.bsky.social @meravcohen.bsky.social

#Neutrophils #PIC-seq #BreastCancer #TME
April 2, 2025 at 6:40 AM
natcancer.nature.com
🍂Our September issue is OUT NOW!

Featuring, among others:
- A Perspective on #drugconjugates
- #immunotherapy studies
- research on GBM invasion
- method for #singlecell analyses of #CTCs

🔗 www.nature.com/natcancer/vo...
September 25, 2025 at 11:05 AM
bruzos.bsky.social
Happy to start my adventure in @bsky.app by announcing November's Nature Cancer cover featuring our work and @metzgerm.bsky.social! www.nature.com/natcancer/vo...
Nature Cancer, volume 4, issue 11. https://www.nature.com/natcancer/volumes/4/issues/11
November 23, 2023 at 2:25 AM
natcancer.nature.com
❄️Our January Issue is out!

Featuring:
☑️Review on GBM immunity
☑️immune atlas in multiple myeloma
☑️tumor microbiome in head & neck cancer
☑️MEK–RAF molecular glue against RAS/BRAF-mutant cancers
☑️atypical EMT
☑️CheckMate 77T phase 3 trial in patients with NSCLC
and more!

www.nature.com/natcancer/vo...
January 30, 2026 at 7:12 PM
natcancer.nature.com
🍂In case you haven't yet done so, check out our October issue now!

🔗 www.nature.com/natcancer/vo...
November 19, 2025 at 11:40 AM
natcancer.nature.com
🌟Check out our May Issue now!

Read about:
- The circadian clock in cancer
- TIL therapy in lung cancer
- A 4-1BB co-stimulated anti-CD19 CAR-NK cell therapy
- TME dynamics of neoadjuvant therapy in esophageal adenocarcinoma
- a SCLC organoid biobank
and more!

www.nature.com/natcancer/vo...
June 9, 2025 at 10:42 AM
natcancer.nature.com
Inside April Issue: have a look at Nature Cancer issue featuring GEP-NETs, CART, prostate cancer, renal cell carcinoma, bacteria in cancer therapy, gallbladder lesions, lung cancer, ESMO TAT reports, and much more

👉 nature.com/natcancer/
April 28, 2025 at 3:25 PM
haoyin.bsky.social
Vascular Rarefaction precedes #Cachexia Cancer-induced #SkeletalMuscle Wasting

A remote Tumor (⏫Activin A)-Muscle (⏬#EndothelialCell PGC1α) crosstalk

Lenti-Cdh5-PGC1α intramuscular⏬Cachexia

tumor⏫ SkM EC #EndMT OXPHOS ROS

#Myosky
@jalees.bsky.social #NatCancer 2025
www.nature.com/articles/s43...
May 26, 2025 at 6:42 PM
natcancer.nature.com
🌷Our April Issue is out!

Featuring:
☑️Our Series on Tumor Heterogeneity and Plasticity
☑️CAR T cell therapy in solid tumors
☑️An erythrocyte–anti-PD1 conjugate
☑️Mitigation of immune-related toxicities
☑️Pediatric tumors classification using cfDNA methylation
and more!
www.nature.com/natcancer/vo...
May 1, 2026 at 4:26 PM
natcancer.nature.com
Our August issue is OUT NOW! ☀️
Check it out here:
🔗 www.nature.com/natcancer/vo...

⭐️Featuring:
- review on #nanotechnology for immuno-oncology
- review on #ferroptosis for #cancertherapy
- AI in clinical oncology
- cancer #cachexia
- #immunotherapy clinical trial
August 27, 2025 at 10:30 AM
natcancer.nature.com
📢Our September Issue is out!

Read about generative AI for digital pathology, cancer immunometabolism, GITR antibody optimization, l-glutamine combination therapy, and more

🔗https://www.nature.com/natcancer/volumes/7/issues/9
September 28, 2026 at 1:36 PM
natcancer.nature.com
Our August issue is live!🏖️

Featuring copper dependency in AML, iron-mediated ferroptosis, GPNMB-directed CAR-T cell therapy, IDH1-mutant vaccine in phase 1 trial, and more

🔗 nature.com/natcancer/vo...
August 21, 2026 at 3:43 PM
natcancer.nature.com
Now online - Article

"Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling"

✏️by Roberto Würth & Andreas Trumpp and team

🔗https://www.nature.com/articles/s43018-024-00882-2?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling - Nature Cancer
Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the neuregulin 1–HER3 axis as important ...
www.nature.com
January 8, 2025 at 12:11 PM
natcancer.nature.com
Resource article now online @NatureCancer
'An organoid library unveils subtype-specific IGF-1 dependency via a YAP–AP1 axis in human small cell lung cancer'

✏️By Toshiro Sato & colleagues
📎https://www.nature.com/articles/s43018-025-00945-y?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer
May 6, 2025 at 12:20 PM
natcancer.nature.com
🚨Don't miss the July issue of Nature Cancer!

Check it out here:
🔗 www.nature.com/natcancer/vo...

Featuring:
⭐️Review on clonal hematopoiesis in cancer
⭐️Review on CAR engineering for cancer therapy
⭐️immunotherapy
⭐️AI for tumour classification
⭐️single-cell analyses in B-ALL
July 30, 2025 at 12:01 PM
natcancer.nature.com
ONLINE now! @naturecancer.bsky.social

✏️By Helen He Zhu & colleagues: 'A Gremlin 1-expressing splenic niche cell population restrains CML by antagonizing the BMP pathway'

🔗https://www.nature.com/articles/s43018-025-00933-2?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer
A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway - Nature Cancer
Zhu and colleagues show that a subpopulation of spleen-derived fibroblasts secrete Gremlin 1, which suppresses chronic myeloid leukemia progression by inducing leukemia stem cell apoptosis through the...
www.nature.com
April 7, 2025 at 12:32 PM
natcancer.nature.com
🌻Check out our June issue !

✅Metastatic dissemination in CRC
✅Immunotherapy in GBM
✅BH3 mimetics sensitization in AML
✅ctDNA and PSA to monitor prostate cancer
✅Methylation-based CNS tumor classification
and more...

www.nature.com/natcancer/vo...
July 6, 2026 at 9:13 PM
natcancer.nature.com
☀️Check out our July issue!

✅Tertiary lymphoid structures
✅DNA vaccine for GBM
✅CAR T cell therapy in lung metastases
✅Adjuvant chemotherapy in nasopharyngeal carcinoma
✅Neutrophil-driven contact-dependent immune suppression
✅GABA in GBM immunity
✅Tumor glycosylation
www.nature.com/natcancer/vo...
August 3, 2026 at 7:57 AM
natcancer.nature.com
🚨Our JUNE Issue is OUT NOW! ☀️

Check it out here:

🔗 www.nature.com/natcancer/vo...
Nature Cancer - Detecting minimal residual cancer from ctDNA
A tumor-agnostic assay for detecting minimal residual cancer based on whole-exome sequencing of longitudinal ctDNA samples after surgery.See...
www.nature.com
June 30, 2025 at 10:36 AM
natcancer.nature.com
🍓☀️Check out our May Issue, now live!

Including:
☑️Oncolytic virus and cytokine-based gene therapies
☑️Myeloid plasticity, part of our Series on Tumor Heterogeneity and Plasticity
☑️DeepFAN, a model for human-AI collaboration
and more!

www.nature.com/natcancer/vo...
June 3, 2026 at 6:18 AM
takamasao.bsky.social
Bispecific ChTCRs (Bi-ChTCRs) targeting CD19/CD22 or BCMA/SLAMF7 surpass CAR-T in recognizing antigen-low tumors and eradicating heterogeneous cancers. TCR knockout enhances Bi-ChTCR expression and sensitivity, preventing mispairing with endogenous chains.

NatCancer: www.nature.com/articles/s43...
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy - Nature Cancer
Simon, Bugos and colleagues report the design and characterization of monospecific and bispecific synthetic chimeric T cell receptors, conferring increased antigen sensitivity and antitumor activity i...
www.nature.com
March 17, 2025 at 11:40 PM